Association between taurine transporter SLC6A6 and breast cancer development and prognosis: a Mendelian randomization analysis
Abstract Background Breast cancer is the most common malignancy among women worldwide, with early screening and diagnosis being crucial for improving patient prognosis. Taurine, as an important metabolite, shows significant changes during breast cancer development, while the taurine transporter SLC6...
Saved in:
| Main Authors: | Xinping Huang, Hailong Shu, Man Xu, Weixiao Ke, Wanting Chen, Wenbin Huang, Hai Wang, Yifan Zhu, Yongxia Yang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-07-01
|
| Series: | Discover Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s12672-025-03246-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Glutamate transporter SLC1A6 promotes resistance to immunotherapy in cancer
by: Chenchen Li, et al.
Published: (2025-06-01) -
Evaluation of SLC6A8 species conservation and the effect of pathogenic variants on creatine transport
by: Taryn Diep, et al.
Published: (2025-10-01) -
SLC6A20 transporter: a novel regulator of brain glycine homeostasis and NMDAR function
by: Mihyun Bae, et al.
Published: (2021-01-01) -
Effects of SLC6A8 mutation-induced creatine deficiency on cellular function in fibroblasts
by: Shingo Ito, et al.
Published: (2025-07-01) -
Pan-Cancer Characterization Identifies SLC19A1 as an Unfavorable Prognostic Marker and Associates It with Tumor Infiltration Features
by: Yimin Pan, et al.
Published: (2025-02-01)